Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide
- 1 February 1997
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1360 (1), 17-29
- https://doi.org/10.1016/s0925-4439(96)00062-2
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Advanced glycation endproducts — associated parameters in the peripheral blood of patients with Alzheimer's diseaseLife Sciences, 1996
- Self-association of β-Amyloid Peptide (1–40) in Solution and Binding to Lipid MembranesJournal of Molecular Biology, 1995
- Non‐enzymatic glycosylation of the dipeptide l‐carnosine, a potential anti‐protein‐cross‐linking agentFEBS Letters, 1995
- Age as Risk Factor for Sporadic Dementia of the Alzheimer Type?Annals of the New York Academy of Sciences, 1994
- Activation of Macrophages by Alzheimer β Amyloid PeptideBiochemical and Biophysical Research Communications, 1994
- Serum Advanced Glycosylation End Products: A New Class of Uremic Toxins?Blood Purification, 1994
- Active microglia, sick astroglia and Alzheimer type dementiasNeuroReport, 1994
- Die Bedeutung der Maillard-Reaktion in der menschlichen PhysiologieZeitschrift Fur Ernahrungswissenschaft, 1991
- The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteinsExperimental Eye Research, 1990
- Blood-Brain Glucose Transfer: Repression in Chronic HyperglycemiaScience, 1981